In a landmark move that signals the institutionalization of psychedelic medicine, pharmaceutical giant Eli Lilly has announced...
Treatment Innovations
In a landmark study that underscores the transformative potential of artificial intelligence in clinical medicine, the American...
In a significant move to reshape the diagnostic landscape for chronic respiratory diseases, bioAffinity Technologies has announced...
For years, the narrative surrounding classic psychedelics—specifically psilocybin—has been one of near-messianic promise. Propelled by early, small-scale...
In a landmark development for neuro-ophthalmology and bioelectronics, California-based Science Corporation has officially launched its Prima system...
The pharmaceutical landscape underwent significant shifts this week, with major updates emerging from late-stage clinical trials, strategic...
Vertex Pharmaceuticals’ recent $10 billion acquisition of Crinetics Pharmaceuticals has sent shockwaves through the biotechnology sector, triggering...
In a milestone development that promises to reshape the landscape of modern medicine, Johnson & Johnson (J&J)...
In a significant advancement for genetic medicine, Arrowhead Pharmaceuticals has announced resounding success in two late-stage clinical...
In the high-stakes world of biopharmaceutical manufacturing, the transition of a product from the laboratory bench to...
